Purpose: The guidelines of the German, European, and American Urological Associations on urolithiasis advise against general ureteral stenting before and after an uncomplicated ureterorenoscopy (URS). However, German and European guidelines state that stenting prior to URS facilitates stone extraction and reduces intraoperative complications. According to the published literature, German practice seems to deviate from recommendations. This nationwide survey aimed to evaluate the treatment modalities of urolithiasis. Methods: In November 2018 and March 2019, a total of 199 urological hospital departments in Germany were anonymously surveyed about operative care of symptomatic urolithiasis. The response rate was 72.9%. The survey consisted of 25 questions about diagnostics, surgical technique, and aftercare of the URS. This questionnaire is available in the appendix. Results: A primary URS is performed in ≤10% in 49.6% of the hospitals. In every second urological department (49.7%), the German Diagnosis Related Group (G-DRG) system influences the period of pre-stenting before a secondary URS. After a secondary URS, which is performed in 53.8% of the departments in over 80% of the patients, 14% of the departments omit stenting. The standard for stenting seems to be a 28-cm-long 7 Charrière double-J stent in Germany. Conclusion: In Germany, the percentage of primary URS is low, and a ureter stenting is performed in most of the urological departments after URS. Delaying therapy due to economic aspects is the standard in almost half of all urological departments.

1.
Alelign
T
,
Petros
B
.
Kidney stone disease: an update on current concepts
.
Adv Urol
.
2018
;
2018
:
3068365
.
2.
Hesse
A
,
Brändle
E
,
Wilbert
D
,
Köhrmann
K-U
,
Alken
P
.
Study on the prevalence and Incidence of urolithiasis in Germany comparing the years 1979 vs
.
2000
.
Eur Urol
.
2003
;
44
(
6
):
709
13
.
3.
Arbeitskreis Harnsteine der Akademie der Deutschen Urologen. S2k-Leitlinie zur Diagnostik
..
Therapie und Metaphylaxe der Urolithiasis
.
2018
.
4.
Lebentrau
S
,
May
M
,
Ziegler
H
, et al.
Die Empfehlungen der S2k-Leitlinie zur Diagnostik, Therapie und Metaphylaxe der Urolithiasis bilden einen sicheren Handlungskorridor für die ureterorenoskopische Steintherapie – Ergebnisse der BUSTER-Studie
.
Aktuelle Urol
.
2018
;
49
(
2
):
164
70
.
5.
EAU Guidelines Office
.
Arnhem, The Netherlands (ed.): EAU Guidelines: dilatation of the upper urinary tract (UPJ and UVJ obstruction)
.
2019
.
2019
.
6.
Assimos
D
,
Krambeck
A
,
Miller
NL
,
Monga
M
,
Murad
MH
,
Nelson
CP
, et al.
Surgical management of stones
.
J Urol
.
2016 Oct
;
196
(
4
):
1153
60
.
7.
Werthemann
P
,
Weikert
S
,
Enzmann
T
,
Schostak
M
,
Lebentrau
S
.
A Stent for every stone? Prestenting habits and outcomes from a German Multicenter Prospective Study on the Benchmarks of Ureteroroscopic Stone Treatment (BUSTER)
.
Urol Int
.
2020
:
1
6
.
8.
Haleblian
G
,
Kijvikai
K
,
de La Rosette
J
,
Preminger
G
.
Ureteral stenting and urinary stone management: a systematic review
.
J Urol
.
2008
;
179
(
2
):
424
30
.
9.
Joshi
HB
,
Stainthorpe
A
,
MacDonagh
RP
,
Keeley
FX
,
Timoney
AG
,
Barry
MJ
.
Indwelling ureteral stents: evaluation of symptoms, quality of life and utility
.
J Urol
.
2003
;
169
(
3
):
1065
9
;
discussion 1069
.
10.
Ordonez
M
,
Hwang
EC
,
Borofsky
M
,
Bakker
CJ
,
Gandhi
S
,
Dahm
P
.
Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi
.
Cochrane Database Syst Rev
.
2019
;
2
:
CD012703
.
11.
Geraghty
RM
,
Jones
P
,
Somani
BK
.
Worldwide trends of urinary stone disease treatment over the last two decades: a systematic review
.
J Endourol
.
2017
;
31
(
6
):
547
56
.
12.
EAU
-
Guidelines
-Urolithiasis-2016-1.
13.
Bach
P
,
Reicherz
A
,
Teichman
J
, et al.
Short-term external ureter stenting shows significant benefit in comparison to routine double-J stent placement after ureterorenoscopic stone extraction: a prospective randomized trial - the Fast track Stent Study (FaST)
.
Int J Urol
.
2018
;
25
(
8
):
717
22
.
14.
Mittakanti
HR
,
Conti
SL
,
Pao
AC
, et al.
Unplanned emergency department visits and hospital admissions following ureteroscopy: do ureteral stents make a difference?
Urology
.
2018
;
117
:
44
9
.
15.
Nestler
S
,
Witte
B
,
Schilchegger
L
,
Jones
J
.
Size does matter: ureteral stents with a smaller diameter show advantages regarding urinary symptoms, pain levels and general health
.
World J Urol
.
2019
.
16.
Deininger
S
,
Haberstock
L
,
Kruck
S
, et al.
Single-use versus reusable ureterorenoscopes for retrograde intrarenal surgery (RIRS): systematic comparative analysis of physical and optical properties in three different devices
.
World J Urol
.
2018
;
36
(
12
):
2059
63
.
17.
Reicherz
A
,
Maas
V
,
Wenzel
P
, et al.
Transient stent placement versus tubeless procedure after ureteroscopy retrograde surgery stone extraction (FaST 2): a randomized prospective evaluation
.
Int J Urol
.
2020
.
18.
Borghi
L
,
Meschi
T
,
Amato
F
,
Briganti
A
,
Novarini
A
,
Giannini
A
.
Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study
.
J Urol
.
1996
;
155
(
3
):
839
43
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.